Novanta acquires Riverpoint Medical for $1.45 billion
Novanta entered a definitive agreement to acquire Riverpoint Medical from Arlington Capital Partners for $1.2 billion upfront cash and a $250 million milestone payment in Q1 2027. Riverpoint is a developer of minimally invasive surgical consumables. The transaction is expected to close in Q3 2026.
Productsminimally invasive surgical consumablesadvanced surgical fibers
“Novanta Inc. today announced that it has entered into a definitive agreement to acquire Riverpoint Medical”investors.novanta.com
- 4 sources
- investors.novanta.comNovanta Inc. - Novanta Inc. Announces Acquisition of Riverpoint MedicalJun 9, 2026
- axios.comNovanta to acquire Riverpoint Medical for $1.5BBrock E.W. TurnerJun 9, 2026
- arlingtoncap.comArlington Capital Partners to Sell Riverpoint Medical to Novanta - ACPJun 10, 2026
- textileworld.comNovanta Inc. Announces Acquisition Of Riverpoint Medical — Known For Utilizing Highly Specialized Implantable Surgical Fibers | Textile WorldJim BornemanJun 19, 2026
Summarized from public sources; check the original articles before acting on it.